Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 14 of 14 entries
View as:

KL₄Surfactant Treatment in Patients With ARDS

Phase: N/A Priority: Normal
NCT ID: NCT00215553 Org: User:
Start: 05/31/01 End: 02/28/06 Due: 02/28/07

A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age

Phase: N/A Priority: Normal
NCT ID: NCT04264156 Org: User:
Start: 04/18/20 End: 03/28/21 Due: 03/28/22

A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C

Phase: N/A Priority: Normal
NCT ID: NCT05975021 Org: User:
Start: 06/01/24 End: 01/31/25 Due: 01/31/26

SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.

Phase: N/A Priority: Normal
NCT ID: NCT00215540 Org: User:
Start: 02/28/05 End: 07/31/06 Due: 07/31/07

Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates

Phase: N/A Priority: Normal
NCT ID: NCT02074059 Org: User:
Start: 02/28/14 End: 11/30/15 Due: 11/30/16

Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00004500 Org: User:
Start: 03/31/00 End: 11/30/04 Due: 11/30/05

Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old

Phase: N/A Priority: Normal
NCT ID: NCT00578734 Org: User:
Start: 06/30/07 End: 04/30/10 Due: 04/30/11

Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants

Phase: N/A Priority: Normal
NCT ID: NCT00807235 Org: User:
Start: 01/31/05 End: 09/30/05 Due: 09/30/06

The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT02617446 Org: User:
Start: 12/31/15 End: 02/06/19 Due: 02/06/20

Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan

Phase: N/A Priority: Normal
NCT ID: NCT03217825 Org: User:
Start: 12/31/15 End: 02/08/18 Due: 02/08/19

The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock

Phase: N/A Priority: Normal
NCT ID: NCT04325035 Org: User:
Start: 09/28/20 End: 10/30/24 Due: 10/30/25

The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT04389671 Org: User:
Start: 01/05/21 End: 02/20/22 Due: 02/20/23

The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age

Phase: N/A Priority: Normal
NCT ID: NCT02636868 Org: User:
Start: 12/31/15 End: 08/06/19 Due: 08/06/20

Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA

Phase: N/A Priority: Normal
NCT ID: NCT02528318 Org: User:
Start: 08/31/15 End: 08/11/17 Due: 08/11/18